Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia

Background Hepatitis B and C viruses are important health and socioeconomic problem across the globe, with a remarkable number of diseases and deaths in sub-Saharan African countries. The burden of hepatitis is unknown in the prison settings of Tigrai. Therefore, we aimed to describe the seroprevalence and associated factors of hepatitis B and C viruses among prisoners in Tigrai, Ethiopia. Methods A cross-sectional study was carried out from February 2020 to May 2020 at the prison facilities of Tigrai. Demographics and associated factors were collected from 315 prisoners prospectively. Five milliliters of blood was collected and tested using rapid tests kits of HBsAg (Zhejiang orient Gene Biotech Co., Ltd., China) and HCV antibodies (Volkan Kozmetik Sanayi Ve Ticaret Ltd. STI, Turkey). Positive samples were confirmed using enzyme-linked immunosorbent assay (ELISA) (Beijing Wantai Biological Pharmacy Enterprise Co. Ltd). Data were analyzed using the Statistical Package for Social Sciences (SPSS) version 20 and p<0.05 was considered statistically significant. Results The overall seroprevalence of HBV and HCV were 25 (7.9%) and 1 (0.3%), respectively. The majority of hepatitis B viral infections were identified from the age groups of 18–25 years (10.7%) and unmarried prisoners (11.8%). Prisoners greater than 100 per cell (AOR=3.95, 95% CI=1.15–13.6, p=0.029) and with a history of alcohol consumption (AOR=3.01, 95% CI=1.17–7.74, p=0.022) were significantly associated with HBV infections. Conclusion The seroprevalence of HBV among prisoners was nearly high or borderline (7.9%) with a very low HCV prevalence (0.3%). HBV was most prevalent among young adults, those housed with a large number of prisoners per cell, and those who had a history of alcohol consumption. This study recommends that there should be prison-focused intervention, including regular health education, with the emphasis on the mode of transmission and introducing HBV screening policy for prisoners, especially when they enter the prison.

[1]  N. Salari,et al.  Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis , 2022, Archives of Virology.

[2]  D. Pella,et al.  What is the Role of the Horizontal Transmission of Hepatitis B Virus Infection in Young Adult and Middle-Aged Roma Population Living in the Settlements in East Slovakia? , 2020, International journal of environmental research and public health.

[3]  A. Duberg,et al.  Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County , 2019, BMC Infectious Diseases.

[4]  S. Kose,et al.  Hepatitis B and Hepatitis C in prisons: a prevalence study. , 2019, International journal of prisoner health.

[5]  N. Berhe,et al.  Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia , 2019, bioRxiv.

[6]  I. Adeoye,et al.  Knowledge, Serological Markers and Risk Factors associated with Hepatitis B and C Virus Infection among Kuje Prison Inmates, Federal Capital Territory, Nigeria , 2018, International Journal of Infectious Diseases.

[7]  S. Baggio,et al.  Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison , 2018, Journal of global health.

[8]  Selam Niguse,et al.  Prevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three‐year retrospective study , 2018, Journal of medical virology.

[9]  G. Moradi,et al.  Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015 , 2018, Tropical medicine & international health : TM & IH.

[10]  Y. Hutin,et al.  How far are we from viral hepatitis elimination service coverage targets? , 2018, Journal of the International AIDS Society.

[11]  N. Berhe,et al.  Hepatitis B virus infection and associated risk factors among pregnant women attending antenatal care in health facilities of Tigray, Northern Ethiopia , 2018, Journal of medical virology.

[12]  Z. Mekonnen,et al.  Seroprevalence and risk factors of hepatitis B, hepatitis C and HIV infections among prisoners in Jimma Town, Southwest Ethiopia , 2017 .

[13]  G. Ribeiro,et al.  Potential use of saliva samples to diagnose Zika virus infection , 2017, Journal of medical virology.

[14]  Kasey McCall-Smith.  United Nations Standard Minimum Rules for the Treatment of Prisoners (Nelson Mandela Rules) , 2016, International Legal Materials.

[15]  F. Altice,et al.  Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment. , 2016, The International journal on drug policy.

[16]  Zewdie Oltaye,et al.  Assessment of Magnitude of Sexually Transmitted Infections, Sexual and Reproductive Health Status among Prisoners Aged Between 18-49 Years in Tabor Prison, Hawassa, Ethiopia , 2016 .

[17]  C. Beyrer,et al.  Public health and international drug policy , 2016, The Lancet.

[18]  T. Asmelash,et al.  Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia , 2016, AIDS Research and Therapy.

[19]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[20]  B. Cowie,et al.  Hepatitis B virus epidemiology. , 2015, Cold Spring Harbor perspectives in medicine.

[21]  K. van Dooren,et al.  Risk of death for young ex‐prisoners in the year following release from adult prison , 2013, Australian and New Zealand journal of public health.

[22]  Z. Saad,et al.  Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. , 2013, Journal of infection and public health.

[23]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[24]  S. Kinner,et al.  High-risk drug-use practices among a large sample of Australian prisoners. , 2012, Drug and alcohol dependence.

[25]  B. Ataei,et al.  Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran , 2012, International journal of preventive medicine.

[26]  H. Ziglam,et al.  Prevalence of antibodies to human immunodeficiency virus, hepatitis B, and hepatitis C in prisoners in Libya , 2012, The Libyan journal of medicine.

[27]  F. Emmrich,et al.  Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years , 2010, BMC infectious diseases.

[28]  Sami Ramia,et al.  Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. , 2010, Journal of infection in developing countries.

[29]  R. Mikulić,et al.  Viral hepatitis B, C and HIV infection in Croatian prisons , 2010, Epidemiology and Infection.

[30]  G. Degu,et al.  Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia , 2009 .

[31]  N. Beeching,et al.  Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. , 2008, The Journal of infection.

[32]  Michael Massoglia.  Incarceration as Exposure: The Prison, Infectious Disease, and Other Stress-Related Illnesses∗ , 2008, Journal of health and social behavior.

[33]  J. Bick.  Infection control in jails and prisons. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Strathdee,et al.  HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan , 2007, Emerging infectious diseases.

[35]  G. La Torre,et al.  Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners , 2007, BMC infectious diseases.

[36]  A. Adjei,et al.  Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. , 2006, Journal of medical microbiology.

[37]  S. Gebre-selassie,et al.  Seroprevalence of HBsAg and its risk factors amoung pregnant women in Jimma, Southwest Ethiopia , 2005 .

[38]  J. Boivin,et al.  Hepatitis B virus infection among street youths in Montreal. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[39]  G. Robaeys,et al.  Hepatitis C Viral Infection in Prisons , 2017 .

[40]  R. Wilcox.  Hepatocellular carcinoma and HIV: is there an association? , 2009, HIV clinician.

[41]  J. Baillargeon,et al.  Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. , 2003, Public health.